write a research paper
Perform preliminary research on the assigned ethical dilemma. Determines the ethical principles that apply to each position, possible conflicts in principles, and components of the ANA Code of Ethics that apply using three (3) Provisions.
Should a child with an organ transplant, who stops taking anti-rejection medications, be allowed back on the transplant list?
2-3 papers
Expert Solution Preview
Introduction:
The ethical dilemma presented is whether a child with an organ transplant, who stops taking anti-rejection medications, should be allowed back on the transplant list. This is a complex issue that involves balancing considerations of the child’s health and well-being, the resources and policies of the transplant program, and the ethical principles governing medical decision-making. In this research paper, we will explore the different ethical perspectives and principles that apply to this dilemma, including the provisions of the ANA Code of Ethics.
Answer:
To begin, it is important to note that the child’s health and well-being should be the primary concern of healthcare providers and transplant programs. However, in this case, the child’s decision to stop taking anti-rejection medications puts them at increased risk of organ rejection and potentially life-threatening complications. Additionally, if the child were to receive another transplant, there is a risk that they may again stop taking their medications, leading to the same outcome.
From an ethical perspective, there are several principles that apply to this dilemma. First, the principle of beneficence, which requires healthcare providers to act in the best interests of their patients, would suggest that the child should not be allowed back on the transplant list. Allowing the child to receive another transplant when they have demonstrated noncompliance with medication regimens would not be in their best interests.
On the other hand, the principle of autonomy, which emphasizes the patient’s right to make decisions about their own healthcare, would suggest that the child should be allowed to make their own decision about whether to take anti-rejection medications and whether to pursue another transplant. If the child is capable of making an informed decision and understands the risks involved, their autonomy should be respected.
The ANA Code of Ethics also provides guidance on this issue. Provision 1 states that nurses must practice with compassion and respect for the inherent dignity, worth, and uniqueness of every individual, which would suggest that the child’s autonomy and values should be respected. However, Provision 2 also states that nurses must safeguard the patient’s health and welfare, which may conflict with the principle of autonomy in this case.
In conclusion, the decision of whether a child with an organ transplant who stops taking anti-rejection medications should be allowed back on the transplant list is a complex ethical dilemma. Healthcare providers and transplant programs must balance the health and well-being of the child with the ethical principles of beneficence and autonomy, as well as the provisions of the ANA Code of Ethics. Ultimately, the decision should be based on a careful consideration of all these factors and an individualized approach to each case.